stockrowThermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.
- Revenue
- +9.13%
- EPS
- +8.64%
- Free cash flow
- +15.0%
- Total debt
- +22.8%
Quarter to September 2026, against a year earlier
Follow TMO
Alert me
Thermo Fisher Scientific Inc. (TMO) Free cash flow
Thermo Fisher Scientific Inc.'s free cash flow for fiscal 2025 was $6.3B, down 13.5% from $7.3B in fiscal 2024. Over the twelve months to 30 September 2026 it was $7.6B. Over the past ten years it has ranged from $2.5B (fiscal 2015) to $7.3B (fiscal 2024); the current reading is higher than 55% of that period. Thermo Fisher Scientific Inc. ranks 1st of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $6.3B | (13.48%) |
| FY2024 | $7.3B | 4.42% |
| FY2023 | $7.0B | 1.14% |
| FY2022 | $6.9B | 1.85% |
| FY2021 | $6.8B | (0.21%) |
| FY2020 | $6.8B | 67.11% |
| FY2019 | $4.1B | 6.47% |
| FY2018 | $3.8B | 9.45% |
| FY2017 | $3.5B | 23.38% |
| FY2016 | $2.8B | 11.94% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $2.1B | 25.91% |
| Jun 2026 | $1.7B | 103.52% |
| Mar 2026 | $825.0M | (72.67%) |
| Dec 2025 | $3.0B | 64.17% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| TMO Thermo Fisher Scientific Inc. | $7.6B |
| DHR Danaher Corporation compare | $5.8B |
| IQV IQVIA Holdings Inc. compare | $2.1B |
| IDXX IDEXX Laboratories, Inc. compare | $1.3B |
| A Agilent Technologies, Inc. compare | $1.3B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $864.0M |
| WAT Waters Corporation compare | $258.4M |
| NTRA Natera, Inc. compare | $52.5M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement